Delivery Order SPE2DB22D1017-SPE2DB25FE9DL

Award Date 11/14/24
Potential Completion Date 11/15/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE9DL
    Delivery Order

This federal contract award, with ID SPE2DB22D1017|SPE2DB25FE9DL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,035.76 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has a performance period through November 15, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 Indefinite Delivery Contract with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/13/25, 9:18 AM